Deutsche Bank’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $305K | Hold |
|
|||||
|
2023
Q4 | $272K | Hold |
|
|||||
|
2023
Q3 | $161K | Hold |
|
|||||
|
2023
Q2 | $348K | Sell |
|
|||||
|
2023
Q1 | $831K | Buy |
|
|||||
|
2022
Q4 | $799K | Buy |
|
|||||
|
2022
Q3 | $1.56M | Sell |
|
|||||
|
2022
Q2 | $1.67M | Buy |
|
|||||
|
2022
Q1 | $1.49M | Sell |
|
|||||
|
2021
Q4 | $2.37M | Buy |
|
|||||
|
2021
Q3 | $3.06M | Buy |
|
|||||
|
2021
Q2 | $2.94M | Buy |
|
|||||
|
2021
Q1 | $845K | Buy |
|